Cargando…

Antidepressant effect of recombinant NT4-NAP/AAV on social isolated mice through intranasal route

The purpose of the present study was to observe the depression-like behavior induced by social isolation; detect the antidepressant effect of a recombinant adeno-associated virus (AAV) expressing NAP on social isolation mice by intranasal delivery. After construction of NT4-NAP/AAV, expression of NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fei, Liu, You-ping, Lei, Gang, Liu, Peng, Chu, Zheng, Gao, Cheng-ge, Dang, Yong-hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354645/ https://www.ncbi.nlm.nih.gov/pubmed/28052034 http://dx.doi.org/10.18632/oncotarget.14356

Ejemplares similares

A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression
por: Chen, Ce, et al.
Publicado: (2020)

Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder
por: Ma, Xian-cang, et al.
Publicado: (2016)

Design and Application in Delivery System of Intranasal Antidepressants
por: Xu, Jingying, et al.
Publicado: (2020)

AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy
por: Sahenk, Zarife, et al.
Publicado: (2014)

AAV1.NT-3 gene therapy prevents age-related sarcopenia
por: Ozes, Burcak, et al.
Publicado: (2023)

Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I
por: Belur, Lalitha R., et al.
Publicado: (2021)

Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients
por: Jin, Zhiyu, et al.
Publicado: (2022)

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy
por: Yalvac, M E, et al.
Publicado: (2016)

AAV-mediated NT-3 overexpression protects cochleae against noise-induced synaptopathy
por: Chen, Hengchao, et al.
Publicado: (2018)

Effects of Intranasal Administration of Oxytocin and Vasopressin on Social Cognition and Potential Routes and Mechanisms of Action
por: Yao, Shuxia, et al.
Publicado: (2022)

Toxicological data of rats and rabbits: Sub-chronic testing of recombinant HPV vaccine through oral and intranasal routes
por: Srinivasa Reddy, Y., et al.
Publicado: (2021)

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
por: Magen, Iddo, et al.
Publicado: (2014)

AAV Recombineering with Single Strand Oligonucleotides
por: Hirsch, Matthew L., et al.
Publicado: (2009)

AAV1.NT‐3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia
por: Tong, Lingying, et al.
Publicado: (2023)

Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
por: Zeltner, Nadja, et al.
Publicado: (2010)

The antidepressant effect and safety of non-intranasal esketamine: A systematic review
por: Smith-Apeldoorn, Sanne Y, et al.
Publicado: (2022)

Caught Napping
Publicado: (1897)

Effects of Nt-truncation and coexpression of isolated Nt domains on the membrane trafficking of electroneutral Na(+)/HCO(3)(–) cotransporters
por: Wang, Deng-Ke, et al.
Publicado: (2015)

The Role of Recombinant AAV in Precise Genome Editing
por: Bijlani, Swati, et al.
Publicado: (2022)

Adding recombinant AAVs to the cancer therapeutics mix
por: Mulcrone, Patrick L., et al.
Publicado: (2022)

To Nap or Not to Nap? A Systematic Review Evaluating Napping Behavior in Athletes and the Impact on Various Measures of Athletic Performance
por: Lastella, Michele, et al.
Publicado: (2021)

CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
por: Mathiesen, Sophie N., et al.
Publicado: (2020)

AAV1.NT-3 gene therapy for X-linked Charcot–Marie–Tooth neuropathy type 1
por: Ozes, Burcak, et al.
Publicado: (2021)

Tailoring Midazolam-Loaded Chitosan Nanoparticulate Formulation for Enhanced Brain Delivery via Intranasal Route
por: Shrestha, Nikesh, et al.
Publicado: (2020)

Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease
por: SUN, LIJUN, et al.
Publicado: (2012)

High-Throughput Functional MicroRNAs Profiling by Recombinant AAV-Based MicroRNA Sensor Arrays
por: Tian, Wenhong, et al.
Publicado: (2012)

Effective Infection with Dengue Virus in Experimental Neonate and Adult Mice through the Intranasal Route
por: Qiu, Minyue, et al.
Publicado: (2022)

The impact of frequent napping and nap practice on sleep-dependent memory in humans
por: McDevitt, Elizabeth A., et al.
Publicado: (2018)

Formulation of Intranasal Mucoadhesive Thermotriggered In Situ Gel Containing Mirtazapine as an Antidepressant Drug
por: Ghazwani, Mohammed, et al.
Publicado: (2023)

Homologous recombination is required for AAV-mediated gene targeting
por: Vasileva, Ana, et al.
Publicado: (2006)

Delayed Disease in Cynomolgus Macaques Exposed to Ebola Virus by an Intranasal Route
por: Johnston, Sara C., et al.
Publicado: (2021)

Study of valproic acid liposomes for delivery into the brain through an intranasal route
por: Jufri, Mahdi, et al.
Publicado: (2022)

NAPS Quality Controls
Publicado: (1985)

NAPS : Quality Controls
Publicado: (1985)

NAPS : RT-PPM
Publicado: (1985)

NAPS : GM Dispatcher
Publicado: (1985)

The Timing of the Circadian Clock and Sleep Differ between Napping and Non-Napping Toddlers
por: Akacem, Lameese D., et al.
Publicado: (2015)

Contributions of memory and brain development to the bioregulation of naps and nap transitions in early childhood
por: Spencer, Rebecca M. C., et al.
Publicado: (2022)

The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route
por: Jiang, Yueyao, et al.
Publicado: (2019)

A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k25j367e1h6klk1o5fr4aelna5